Phototherapy for Vitiligo - 19/11/19

Résumé |
Vitiligo is a common disorder with a severe impact on quality of life. The authors review recent advances in phototherapy for vitiligo focusing on narrowband ultraviolet B including mechanisms, treatment recommendations, and combination therapies. Phototherapy is the first-line treatment of choice for vitiligo with narrowband UVB preferred for widespread vitiligo and excimer used for localized lesions. However, unfamiliarity with prescribing phototherapy may be limiting clinicians from using it to its full potential. This article provides clinicians with the critical information needed to safely and effectively provide phototherapy for their patients with vitiligo.
Le texte complet de cet article est disponible en PDF.Keywords : Phototherapy, Vitiligo, NBUVB, Afamelanotide, Topical calcineurin inhibitors, JAK inhibitors
Plan
| Disclosure: Dr I.H. Hamzavi is an investigator for Incyte and Pfizer. Dr R. Zubair is a subinvestigator for Incyte. |
Vol 38 - N° 1
P. 55-62 - janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
